April 04, 2022
Regeneron Pharmaceuticals has illegally cornered the market for an eye disease treatment over a competitor's cheaper drug in a kickback scheme with a charity, reaping billions of dollars in annual revenue from sales, Horizon Blue Cross Blue Shield of New Jersey said in a lawsuit Monday in Massachusetts federal court.